Table of Contents

1. Bioequivalence of Modified Release Formulations
2. PPT Slide
3. Modified Release Formulations:
4. PPT Slide
5. Chronobiology
6. PPT Slide
7. PPT Slide
8. PPT Slide
9. PPT Slide
10. Willich et al Am J Cardiol 70: 65-68, 1992
11. PPT Slide
12. W.B. White Am J Hypertens 9:29S-33S, 1996.
13. PPT Slide
14. Conclusion:

JPPS 1(2) Table of Contents

Author: Dr.F.Jamali

Email: fjamali@pharmacy.ualberta.ca

Home Page: http://www.ualberta.ca/~pharmc/jamali.htm

PDF Version